Saman Warnakulasuriya

Early detection and prevention of oral cancer: the role of the dental team in saving lives; Oral potentially malignant disorders – challenges in diagnosis & management

  • Professor Warnakulasuriya is an emeritus professor of Oral Medicine and Experimental Pathology at King’s College London, UK, and was the Chairman of the Oral Medicine Division at King’s College Hospital and at Guy’s Hospital, London, from 2005 -2015.
  • He has made major contributions in cancer epidemiology, oral medicine and experimental pathology.
  • He is a leading expert on human carcinogens, especially tobacco, alcohol and areca nut that cause mouth cancer.
  • His early work showed that smokeless tobacco and areca nut cause cancers of the mouth and have led International Agency on Research on Cancer to confirm these substances as Class 1 carcinogens.
  • Professor Warnakulasuriya developed the terminology and classification of oral potentially malignant disorders and studied their natural history and molecular changes during progression to malignancy.
  • He is the Director of the WHO Collaborating Centre for Oral Cancer.
  • Professor Warnakulasuriya was made an Officer of the Order of the British Empire (OBE) by Her Majesty The Queen in 2008 for his services to Medicine.
  • Received the IADR Distinguished Scientist Award in Oral Medicine and Pathology in 2014 and IADR Distinguished Scientist Award in Global Oral Health in 2022.
  • Was elected as a Fellow of King’s College London (FKC) for sustained and significant contributions to the College.
  • Holds the Honorary Life Membership of the International Association for Oral Pathologists.

Nationality: England

Scientific areas: Oral Medicine

6 of november, from 09h00 until 13h00

Auditorium C

Conference summary

Early detection and prevention of oral cancer: the role of the dental team in saving lives

Oral cancer incidence has been increasing in Portugal in the past two decades. Many patients present for treatment at advanced stages of the disease resulting in a low life expectancy. The major risk factors for oral cancer are smoking and excess alcohol use, while a few cases are associated with HPV infection.

General dentists have an essential role to play in both early detection and prevention. This lecture aims to elucidate ways to identify patients with “high-risk” lesions by carrying out a thorough clinical oral examination with the knowledge of early signs and symptoms of oral cancer.

The evidence of the benefits of population and opportunistic screening for reduction in morbidity and mortality from oral cancer will be presented along with clinical management of cases presenting in primary care.

The limitations of commercially available diagnostic adjuncts for early detection need exploration. Late diagnosis and a slow pathway to treatment can severely limit treatment options for patients, who then face poorer survival prospects.

Dentists therefore need to familiarise with the criteria for “urgent referrals to specialists” to reduce delays often noted in a patient’s cancer journey. Primary care approaches for oral cancer prevention will be discussed with special reference to dentist’s role in smoking cession.

Oral potentially malignant disorders – challenges in diagnosis & management

Oral potentially malignant disorders (OPMDs) include oral leukoplakia, proliferative (multifocal) verrucous leukoplakia, erythroplakia, oral submucous fibrosis, oral lichen planus & lichenoid lesions, actinic cheilitis, dyskeratosis congenita, oral graft vs host disease and oral lupus erythematosus.

Differentiation of OPMDs from numerous other white and red patches that can be found in the oral cavity is a diagnostic challenge. In this diverse group of conditions, malignant transformation rates vary significantly within subtypes ranging from around 1 to 2% in oral lichen planus to over 50% in high-risk conditions such as erythroplakia and proliferative verrucous leukoplakia.

A major challenge faced by general dentists who see these conditions in primary care is to assess the risk of an individual patient and to predict who may develop a malignancy. The application of adjunctive chair-side tests is still in a development stage to identify a high-risk lesion.

The presence and severity of oral epithelial dysplasia in a biopsy is considered the gold standard for assessing the risk for malignancy development but sampling errors and the subjectivity of reporting may limit an accurate prediction. Habit interventions i.e smoking cessation, alcohol moderation and improving diet are essential elements in their management.

Dentists have a key role in long term regular follow up and periodic surveillance to detect an early carcinoma developing in an OPMD while high risk lesions may benefit from surgical intervention.

The talk will also focus on the current evidence base, research gaps, and ongoing research to address such gaps.

Congresso da OMD 2025
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.